A recent list of publications from our lab can be found here:
1: Monsivais D, Parks SE, Chandrashekar DS, Varambally S, Creighton CJ. Using cancer proteomics data to identify gene candidates for therapeutic targeting. Oncotarget. 2023 May 4;14:399-412. doi: 10.18632/oncotarget.28420. PMID:37141409.
2: Kriseman ML, Tang S, Liao Z, Jiang P, Parks SE, Cope DI, Yuan F, Chen F, Masand RP, Castro PD, Ittmann MM, Creighton CJ, Tan Z, Monsivais D. SMAD2/3 signaling in the uterine epithelium controls endometrial cell homeostasis and regeneration. Commun Biol. 2023 Mar 11;6(1):261. doi: 10.1038/s42003-023-04619-2. PMID: 36906706; PMCID: PMC10008566.
3: Modukuri RK, Monsivais D, Li F, Palaniappan M, Bohren KM, Tan Z, Ku AF, Wang Y, Madasu C, Li JY, Tang S, Miklossy G, Palmer SS, Young DW, Matzuk MM. Discovery of Highly Potent and BMPR2-Selective Kinase Inhibitors Using DNA-Encoded Chemical Library Screening. J Med Chem. 2023 Feb 9;66(3):2143-2160. doi: 10.1021/acs.jmedchem.2c01886. Epub 2023 Jan 31. PMID: 36719862; PMCID: PMC9924264.
4: Tang S, Parks SE, Liao Z, Cope DI, Blutt SE, Monsivais D. Establishing 3D Endometrial Organoids from the Mouse Uterus. J Vis Exp. 2023 Jan 6;(191):10.3791/64448. doi: 10.3791/64448. PMID: 36688555; PMCID: PMC10208800.
5: Cope DI, Monsivais D. Progesterone Receptor Signaling in the Uterus Is Essential for Pregnancy Success. Cells. 2022 Apr 27;11(9):1474. doi: 10.3390/cells11091474. PMID: 35563781; PMCID: PMC9104461.
6: Tang S, Cope DI, Vasquez YM, Monsivais D. BMP/SMAD1/5 Signaling in the Endometrial Epithelium Is Essential for Receptivity and Early Pregnancy. Endocrinology. 2022 May 1;163(5):bqac043. doi: 10.1210/endocr/bqac043. PMID: 35383354; PMCID: PMC9049119.
7: Monsivais D, Nagashima T, Prunskaite-Hyyryläinen R, Nozawa K, Shimada K, Tang S, Hamor C, Agno JE, Chen F, Masand RP, Young SL, Creighton CJ, DeMayo FJ, Ikawa M, Lee SJ, Matzuk MM. Endometrial receptivity and implantation require uterine
BMP signaling through an ACVR2A-SMAD1/SMAD5 axis. Nat Commun. 2021 Jun 7;12(1):3386. doi: 10.1038/s41467-021-23571-5. PMID: 34099644; PMCID: PMC8184938.
8: McGlade EA, Herrera GG, Stephens KK, Olsen SLW, Winuthayanon S, Guner J, Hewitt SC, Korach KS, DeMayo FJ, Lydon JP, Monsivais D, Winuthayanon W. Cell-type specific analysis of physiological action of estrogen in mouse oviducts. FASEB J. 2021 May;35(5):e21563. doi: 10.1096/fj.202002747R. PMID: 33818810; PMCID: PMC8189321.
9: Monsivais D, Vasquez YM, Chen F, Zhang Y, Chandrashekar DS, Faver JC, Masand RP, Scheurer ME, Varambally S, Matzuk MM, Creighton CJ. Mass-spectrometry-based proteomic correlates of grade and stage reveal pathways and kinases associated with aggressive human cancers. Oncogene. 2021 Mar;40(11):2081-2095. doi: 10.1038/s41388-021-01681-0. Epub 2021 Feb 24. PMID: 33627787; PMCID: PMC7981264.
10: Monsivais D, Peng J, Kang Y, Matzuk MM. Activin-like kinase 5 (ALK5) inactivation in the mouse uterus results in metastatic endometrial carcinoma. Proc Natl Acad Sci U S A. 2019 Feb 26;116(9):3883-3892. doi: 10.1073/pnas.1806838116. Epub 2019 Jan 17. PMID: 30655341; PMCID: PMC6397539.
11: Kriseman M, Monsivais D, Agno J, Masand RP, Creighton CJ, Matzuk MM. Uterine double-conditional inactivation of Smad2 and Smad3 in mice causes endometrial dysregulation, infertility, and uterine cancer. Proc Natl Acad Sci U
S A. 2019 Feb 26;116(9):3873-3882. doi: 10.1073/pnas.1806862116. Epub 2019 Jan PMID: 30651315; PMCID: PMC6397514.
12: Fullerton PT Jr, Monsivais D, Kommagani R, Matzuk MM. Follistatin is critical for mouse uterine receptivity and decidualization. Proc Natl Acad Sci U S A. 2017 Jun 13;114(24):E4772-E4781. doi: 10.1073/pnas.1620903114. Epub 2017
May 30. PMID: 28559342; PMCID: PMC5474784.
13: Monsivais D, Clementi C, Peng J, Fullerton PT Jr, Prunskaite-Hyyryläinen R, Vainio SJ, Matzuk MM. BMP7 Induces Uterine Receptivity and Blastocyst Attachment. Endocrinology. 2017 Apr 1;158(4):979-992. doi: 10.1210/en.2016-1629.
PMID: 28324064; PMCID: PMC5460793.
Monsivais Lab 